文献速递神经儿科影像MR

预测结节性硬化症相关癫痫患儿的药物治疗结局:一项临床影像组学研究

Predicting Drug Treatment Outcomes in Childrens with Tuberous Sclerosis Complex-Related Epilepsy: A Clinical Radiomics Study.
PubMed 文献 · AJNR Am J Neuroradiol · 2023-06-22

该回顾性研究纳入105例结节性硬化症相关癫痫患儿,从治疗前MR影像提取影像组学特征并结合临床、基因及脑电图数据建模,预测抗癫痫药物治疗结局。测试队列AUC为0.85、准确率80.0%、敏感度0.75、特异度0.83,模型校准曲线良好。作者认为影像组学与临床特征联合模型可能预测癫痫药物治疗结局。

要点

  • 治疗前MR影像的纹理及一阶统计特征对预测结节性硬化症相关癫痫药物结局最有价值。
  • 联合模型含4个MR影像组学特征和5个关键临床特征,测试队列AUC为0.85。
  • 关键临床因素包括发病年龄、婴儿痉挛、抗癫痫药物数量、左顶枕区脑电图痫样放电及基因突变类型。

核心结论

  • 影像组学与临床特征联合模型可能预测结节性硬化症相关癫痫患儿的药物治疗结局。

研究设计与样本

  • 回顾性研究纳入105例结节性硬化症相关癫痫患儿,采用治疗前MR影像提取的影像组学特征及人口学、临床、基因和脑电图数据,以Spearman相关系数和最小绝对收缩和选择算子筛选特征并建模。

诊断标准与关键数值

  • 测试队列预测药物结局的AUC为0.85、准确率80.0%、敏感度0.75、特异度0.83。

临床应用与阅片要点

  • 作者认为发病年龄、婴儿痉挛、抗癫痫药物数量、左顶枕区脑电图痫样放电及基因突变类型是预测药物结局的关键临床因素,纹理及一阶统计特征是预测药物结局最有价值的影像组学特征。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND AND PURPOSE: Highly predictive markers of drug treatment outcomes of tuberous sclerosis complex-related epilepsy are a key unmet clinical need. The objective of this study was to identify meaningful clinical and radiomic predictors of outcomes of epilepsy drug treatment in patients with tuberous sclerosis complex.

MATERIALS AND METHODS: A total of 105 children with tuberous sclerosis complex-related epilepsy were enrolled in this retrospective study. The pretreatment baseline predictors that were used to predict drug treatment outcomes included patient demographic and clinical information, gene data, electroencephalogram data, and radiomic features that were extracted from pretreatment MR imaging scans. The Spearman correlation coefficient and least absolute shrinkage and selection operator were calculated to select the most relevant features for the drug treatment outcome to build a comprehensive model with radiomic and clinical features for clinical application.

RESULTS: Four MR imaging-based radiomic features and 5 key clinical features were selected to predict the drug treatment outcome. Good discriminative performances were achieved in testing cohorts (area under the curve = 0.85, accuracy = 80.0%, sensitivity = 0.75, and specificity = 0.83) for the epilepsy drug treatment outcome. The model of radiomic and clinical features resulted in favorable calibration curves in all cohorts.

CONCLUSIONS: Our results suggested that the radiomic and clinical features model may predict the epilepsy drug treatment outcome. Age of onset, infantile spasms, antiseizure medication numbers, epileptiform discharge in left parieto-occipital area of electroencephalography, and gene mutation type are the key clinical factors to predict the epilepsy drug treatment outcome. The texture and first-order statistic features are the most valuable radiomic features for predicting drug treatment outcomes.

来源:AJNR Am J Neuroradiol,查看原文。版权归原作者所有。

引用

  1. Hu, Jiang, Zhao, et al. Predicting Drug Treatment Outcomes in Childrens with Tuberous Sclerosis Complex-Related Epilepsy: A Clinical Radiomics Study. AJNR Am J Neuroradiol. 2023. PMID: 37348968. doi:10.3174/ajnr.A7911

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。